EUVIMEDEUVIMED entdecken
Crossref

Limosilactobacillus reuteri-educated T cells protect against activation of liver inflammation in immunocompromised mice 2229185

Yuying Liu, Ana Fadhel-Alvarez, Zheng Yin, Beanna Okeugo, Alexander Banerjee, Salomea Giorgberidze, Vaishali Harne, Majji Rambabu, Hari Yalamanchili, Suhair Al Salihi, J Marc Rhoads

The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)

DOI: 10.1093/jimmun/vkag141.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Yuying Liu und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Oral administration of probiotic Limosilactobacillus reuteri DSM 17938 prolongs survival and reduces Th1- and Th2-associated inflammation in Treg-deficient scurfy (SF) mice, which model human IPEX syndrome. It is unclear how DSM 17938 educated SF-CD4+T cells can facilitate T cell-liver communication.

Methods

We adoptively transferred by intraperitoneal injection cells isolated from SF spleens into lymphocyte-deficient-RAG1KO mice and compared the CD4+T cells from SF mice gavage-fed with DSM 17938 with the CD4+T cells from untreated SF mice (Prob-SF-CD4+T cells versus SF-CD4+T cells). Liver inflammatory histology and transcriptomes in RAG1KO mice were analyzed.

Results

We observed that Prob-SF-CD4+T cells reduced the incidence and severity of liver inflammation caused by transferring SF-CD4+T cells. SF-CD4+T cells up-regulated expression of liver genes involved in TLR cascades, inflammatory cytokine and death receptor signals, while down-regulated genes linked to mitochondrial respiratory chain complexes, TCA cycle, liver detoxification and lipid metabolism. However, Prob-SF-CD4+T cell transfer reversed SF-CD4+T cell-induced transcriptomic changes in inflammatory and metabolic clusters by modulating distinct genes participating in TLR regulation, mitochondrial function and cell cycle.

Conclusion

In conclusion, inflammatory CD4+T cells can perpetuate an exaggerated immune response in the immunologically naïve host. DSM17938 has the capacity to reprogram inflammatory CD4+T cells and allowed them to benefit the recipient. Probiotic-modulated T cells can be further explored as a therapeutic option for autoimmune liver diseases. Funding Source National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) R03AI153725 Topic Categories Therapeutic Approaches to Autoimmunity (THER)

Zitieren

APA

Liu, Y., Fadhel-Alvarez, A., Yin, Z., Okeugo, B., Banerjee, A., Giorgberidze, S., Harne, V., Rambabu, M., Yalamanchili, H., Salihi, S. A., & Rhoads, J. M. (2026). Limosilactobacillus reuteri-educated T cells protect against activation of liver inflammation in immunocompromised mice 2229185. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.019

Vancouver

Liu Y, Fadhel-Alvarez A, Yin Z, Okeugo B, Banerjee A, Giorgberidze S, et al. Limosilactobacillus reuteri-educated T cells protect against activation of liver inflammation in immunocompromised mice 2229185. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.019

BibTeX
@article{Liu2026,
  author = {Liu, Yuying and Fadhel-Alvarez, Ana and Yin, Zheng and Okeugo, Beanna and Banerjee, Alexander and Giorgberidze, Salomea and Harne, Vaishali and Rambabu, Majji and Yalamanchili, Hari and Salihi, Suhair Al and Rhoads, J Marc},
  title = {Limosilactobacillus reuteri-educated T cells protect against activation of liver inflammation in immunocompromised mice 2229185},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {Supplement_1},
  doi = {10.1093/jimmun/vkag141.019}
}
Kostenlos starten →